natgillin/translations-raw huggingface dataset:
Der skal udvises forsigtighed hos patienter, som bliver behandlet med methy lphenidat og andre lægemidler, der også kan øge blodtrykket (se også afsnit om cerebrovaskulære lide lser i pkt. 
Caution is advised in patients being treated with methylphenidate with any other drug that can also elevate blood pressure (see also sections on cardiovascular and cerebrovascular conditions in Section 4.4 Warnings and Precautions for use)
Den Tjekkiske Republik 
Slovak republic
se, der havde fundet sted i henhold til artikel 31 i Rådets direktiv 2001/83/EF, med senere ændringer, for lægemidler indeholdende methylphenidat, og f produkter, der lphenidat til n fra 6 år og til unge i EU. 
- The Committee considered the referral made under article 31 of Directive 2001/83/EC, as amended, for medicinal products containing methylphenidate initiated by the European Commission.
Selvmord 
Suicidal tendency
AT - Østrig Medice Arzneimittel Pütter GmbH & Co KG Kuhloweg 37 
AT - Austria Medice Arzneimittel Pütter GmbH & Co KG Kuhloweg 37
and g Tabletten d UCB G Alfred-Nobel-Str. 10 D-40789 Monheim Tyskl 
DE - Germany UCB GmbH Alfred-Nobel-Str. 10 D-40789 Monheim
Når resultaterne af de igangværende undersøgelser med fremsendt til vurdering efter anmodning af CHMP (se ændelser fra kliniske undersøgelser fokus på dette emne foreligger, vil de blive bilag IV). 
In addition the results of the ongoing studies focusing on this issue, once available, will be submitted for assessment as requested by the CHMP (see Annex IV).
Indehaverne af markedsføringstilladelsern der indeholder m kommende tre år, hvorefter rapporteringsfrekvensen PSUR-indsendelse vil gøre det lettere for de kompetente nationale myndigheder vurdering og give et harmoniseret svar i forbindelse med opdateringer af produktresumé/indlægsseddel og risikostyringsplan. 
The synchronisation of the PSUR submission will facilitate a common assessment and harmonised response by the National Competent Authorities on updates of the SPC / PL and RMP.
• event andre familiemedlemmer har eller har haft. 
• about any mental health/psychiatric/behavioural problems you or your child or other family members have or have had in the past.
Patienter med sjælden arvelig fructoseintolerans, glucosegalactosemalabsorption eller sucrose-isomaltasemangel bør ikke tage dette lægemiddel. 
This medicinal product contains sucrose: patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase insufficiency should not take this medicine
Methylphenidat har været i handelen i Europa i årtier til behandling af ADHD (attention deficit stof, der tilhører tering. 
Methylphenidate has been available in Europe for decades for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older.
NOVARTIS FARMA Largo Umberto Bocc 
NOVARTIS FARMA S.P.A. Largo Umberto Boccioni 1 21040 VARESE
Kuldefornemmelse og Raynauds fænomen er også angivet som mulige reaktioner under pkt. 
Peripheral coldness and Raynaud's phenomenon are also listed as possible reactions in section 4.8 of some of the SPCs for methylphenidate.
Langtidsbehandling: 
Long-term treatment
Patienter bør nøje monitoreres for risiko for brug til fornøjelse, forkert brug e methylphenidat. 
Patients should be monitored for the risk of diversion, misuse and abuse of methylphenidate.
I indehaveren af markedsføringstilladelsens gennemgang af spontant indberettede d markedsføringen blev det konkluderet, at cerebrovaskulære hændelser fra spontane indberetninger overvejende bestod af indberettede udtryk: hjerneblødning, slagtilfælde, blodprop og cerebral iskæmi rrende tilfælde uden ndelse med blodprop kæmi. 
The MAH review of post-marketing spontaneous data found that cerebrovascular events from spontaneous reports consisted mainly of the reported terms: cerebrovascular accident, stroke, cerebral infarction and cerebral ischemia as well as a few reports of other events.
Sikkerheden ved langvarig behandling med methylphenidat er ikke fuldstændi leukopeni, trombocytopeni, anæmi eller andre forandringer, inklusive tegn på alvor leversygdomme, bør seponering af behandlingen overvejes. 
In the event of Leukopenia, thrombocytopenia, anaemia or other alterations, including those indicative of serious renal or hepatic disorders, discontinuation of treatment should be considered.
Methylphenidat er indiceret som en del af et omfattende program over 6 år, som ikke har haft tilstrækkelig gavn af behandling udelukkende ved støtteforanstaltninger. 
Methylphenidate is indicated as a part of a comprehensive treatment programme for ADHD in children over 6 years of age where remedial measures alone prove insufficient.
aldersgruppe er i 
Use in the elderly
NO - Norge UCB Nordic A/S Arne Jacobsens Allé 15 
NO - Norway UCB Nordic A/S Arne Jacobsens Allé 15
lvmordstendens stimulerende midler Patienter behandlet med methylphenidat bør monitoreres nøje forværring af aggressiv adfærd eller fjendtlighed ved behandlingsstar efterfølgende minimum hver 6. måned samt ved hver konsultation. 
Patients treated with methylphenidate should be closely monitored for the emergence or worsening of aggressive behaviour or hostility at treatment initiation, at every dose adjustment and then at least every 6 months and every visit.
Screen entere orbide psykiatriske sygdomme eller symptomer, familieanamnese med pludselig hjertedød/uforklarlig død samt omhyggelig angivelse af højde og vægt på en vækstkurve (se pkt. 
A comprehensive history should document concomitant medications, past and present co-morbid medical and psychiatric disorders or symptoms, family history of sudden cardiac/unexplained death and accurate recording of pre-treatment height and weight on a growth chart (see sections 4.3 and 4.4)
Misbrug, forkert brug og diversion 
2.7 Off-label use/misuse/diversion
Konklusionerne af denne vurdering resulterede i en forslag fra CHMP om at skærpe forskellige produktinformationer for produkterne, så de omfattede overvåg opdatering af de afsnit i produktresuméet, der omhandler kontraindikationer og advarsler, 
The conclusions of this assessment led to a CHMP proposal on strengthening and harmonising the respective Product Information of the products with the inclusion of pre- and post-treatment monitoring, updating the sections of the SPC related to the contraindications and warnings, harmonising the information on adverse reactions, checking of the posology and use, updating the information on use in pregnancy and lactation.
Et omfattende behandlingsprogram inkluderer sædvanligvis psykologiske, pædagogiske og sociale adfærdssyndromer er kendetegnet ved symptomer, som kan omfatte en sygehist koncentrationsbesvær, distraktion, følelsesmæssig ustabilitet, impulsivitet, modera hyperaktivitet, mindre neurologiske svækket. 
A comprehensive treatment programme typically includes psychological, educational and social measures as well as pharmacotherapy and is aimed at stabilising children with a behavioural syndrome characterised by symptoms which may include chronic history of short attention span, distractibility, emotional lability, impulsivity, moderate to severe hyperactivity, minor neurological signs and abnormal EEG.
Administration af methylphenidat til psykoti ske patienter kan forværre symptomer på adfærdsændringerne og tankeforstyrrelse. 
Exacerbation of pre-existing Psychotic or manic symptoms In psychotic patients, administration of methylphenidate may exacerbate symptoms of behavioural disturbance and thought disorder.
AT - Østrig Laboratorios Rubio SA C/Industria 29, Poligon Industrial Compte de Sert ES-08755 Castellbisbal (Barcelona) 
AT - Austria Laboratorios Rubio SA C/Industria 29, Poligon Industrial Compte de Sert ES-08755 Castellbisbal (Barcelona)
tilstande eller symptomer gælder for dig eller dit barn. 
This medicine is intended solely for you or for your child.
LABORATORIOS RUBIÓ S A, C/INDUSTRIAL 29, POLIGONO INDUSTRIAL, COMTE DE SERT, CASTELLBISBAL, BARCELONA E08755, SPANIEN 
LABORATORIOS RUBIÓ S A, C/INDUSTRIAL 29, POLIGONO INDUSTRIAL, COMTE DE SERT, CASTELLBISBAL, BARCELONA E08755, SPAIN
af methylphenidat er kontraindiceret ved visse forudeksisterende kardiovaskulære ædiatriske hjertesygdomme (se re alvorlige specialist. 
The use of methylphenidate is contraindicated in certain pre-existing cardiovascular disorders unless specialist paediatric cardiac advice has been obtained (see Section 4.3 ‘Contraindications').
Psykiatriske sygdomme 
Psychiatric disorders
Brug af methylphenidat sammen med alkohol Du eller dit barn må ikke drikke alkohol samtidig med brugen af de forværre medicinens bivirkninger. 
You or your child must not drink alcohol while taking this medicine as alcohol may make this medicine's side effects worse.
Fortæl det til læ tte, at der skal gen, hvis der ikke er nogen bedring i dit barns åneds behandling med methylphenidat. 
Tell the doctor if there is no improvement in your childs condition after 1 month of treatment with methylphenidate.
Indehaverne af markedsføringstilladelserne vil udarbejde fuldt harmoniserede e vil harmonisere PSUR-rapporteringsplanen for produkter, ethylphenidat, og én gang årligt indsende PSUR for deres respektive produkter i de skal gennnemgås igen. 
The MAHs will harmonise the PSUR reporting schedule for methylphenidate-containing products and submit once yearly PSURs for their respective products for the next 3 years, after which the reporting frequency will be reviewed.
Før behandlingen med methylphenidat initieres, skal patienter med komorbide depressive symptomer gennemgå adækvat screening, for at bestemme om de er i bipolar sygdom. 
Prior to initiating treatment with methylphenidate, patients with comorbid depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression.
LT - Litauen UAB „Johnson & Johnson“, Geležinio Vilko g. 18A, LT-08104 Vilnius, Litauen. 
LT - Lithuania UAB „Johnson & Johnson“, Geležinio Vilko g. 18A, LT-08104 Vilnius, Lithuania.
Laboratorios Rubió, S.A. - Calle Industria, 29 - Poligono Industrial Comte de Sert - E-08755 Castellbisbal - Barcelona - Spanien 
Laboratorios Rubió, S.A. - Calle Industria, 29 - Poligono Industrial Comte de Sert - E-08755 Castellbisbal - Barcelona - Spain
Hvis tegn og symptomer ikke er for alvor ved bevidsthed, kan maven tøm 
If the signs and symptoms are not too severe and the patient is conscious, gastric contents may be evacuated by induction of vomiting or gastric lavage.
DK-2300 Kø Danmark 
DK-2300 Kobenhavn S Denmark
Det reproduktive system og mammae Sjælden: Brystforstørrelse 
Reproductive system and breast disorders Rare: Gynaecomastia
• Udvikling af nye eller forværring af forudeksisterende psykiatriske sygdom ved hver dosisjustering og efterfølgende minimum hver 6. måned s 
• development of de novo or worsening of pre-existing psychiatric disorders should be monitored at every adjustment of dose and then least every 6 months and at every visit.
Hvis analysen på baggrund af de aktuelt tilgængelige data vurderes mulig, vil indehaverne af ttelse af analysen og et vurdering af points for følgende psykotiske lidelser) 
If the analysis on the basis of the currently available data is deemed feasible, the MAHs will make the resources available to support the analysis and update the RMP to reflect its findings.
SE - Sverige UCB Nordic A/S Arne Jacobsens Allé 15 
SE - Sweden UCB Nordic A/S Arne Jacobsens Allé 15
Indehaverne af markedsføringstilladelserne indsen understøttede det synspunkt, at der ikke er nogen præklinisk eller klinisk evidens cancinogen risiko i forbindelse med methylphenidat. 
The MAHs submitted data supporting the position that there is no preclinical or clinical evidence for a significant carcinogenic risk associated with methylphenidate.
Ikke almindelig: overfølsomhedsreaktioner som angioneurotisk ødem, anafylaktiske reaktioner, hævelse i det ydre øre, blæredannelse, hudafskalning, nældefeber, kløe, eksem og udslæt. 
Uncommon: hypersensitivity reactions such as angioneurotic oedema, anaphylactic reactions, auricular swelling, bullous conditions, exfoliative conditions, urticarias, pruritis, rashes and eruptions
Patientens alder, tilstedeværelse af risikofaktorer for narkotika/lægemiddel misbrug (såsom samtidig ons- eller trodsforstyrrelser og bipolar sygdom), tidligere eller nuværende stofmisbrug, bør ed hos emotionelt ngighed i anamnesen, da disse patienter ylphenidat eller andre stimulerende midler kan være uegnede til behandling af patienter, som er i 
Patient age, the presence of risk factors for substance use disorder (such as co-morbid oppositionaldefiant or conduct disorder and bipolar disorder), previous or current substance abuse should all be taken into account when deciding on a course of treatment for ADHD.
skland et tten d Janssen-Cilag Gm 41457 Neuss or Janssen Cilag Raiffeisenstr.8 
DE - Germany Janssen-Cilag GmbH 41457 Neuss or Janssen Cilag GmbH Raiffeisenstr.8
ISERLOHN TYSKLAND 
ISERLOHN GERMANY
Endelig vil de relevante afsnit i produktinformationen efter CHMP's anmodning blive ændret med ang til vurderingen og ersøgelser med fokus på dette emne foreligger, vil de blive fremsendt til vurdering efter anmodning af CHMP (se bilag IV). 
Furthermore, the results of the ongoing studies focusing on this issue, once available, will be submitted for assessment as requested by the CHMP (see Annex IV).
10, 20, 30, 40 - Depotkapsler, hårde 
5, 10, 20 mg - tablet 10, 20, 30, 40 - prolongedrelease capsule, hard
Luftveje, thorax og mediastinum Almindelig: hoste, smerte i svælg og strube Ikke almindelig: dyspnø 
Respiratory, thoracic and mediastinal disorders Common: cough, pharyngolaryngeal pain Uncommon: dyspnoea
Din læge kontrollerer nedenstående, før behandlingen med methylphenida 
Checks that your doctor will make before treatment with methylphenidate begins:
CY - Cypern Janssen-Cilag Internation Turnhoutsew al N.V 
CY - Cyprus Janssen-Cilag International N.V. Turnhoutseweg 30
Langvarigt misbrug af methylphenidat kan f unormal adfærd, psykotiske episoder. 
Longstanding abuse of methylphenidate can lead to marked tolerance, psychological dependence, abnormal behaviour, psychotic episodes.
Cerebral vaskulitis synes at være en meget sjælden særegen reaktion på eksponering for omfatte alvorlig hovedpine, følelsesløshed, kraftesløshed, lammelser og svækkelse af koordination, syn, tale, sprog eller hukommelse. 
These symptoms could include severe headache, numbness, weakness, paralysis, and impairment of coordination, vision, speech, language or memory..
På gr behandling (løbende eller inden for de sidste 2 uger) med ikke-selektive, irreversib (se pkt. 
Because of possible hypertensive crisis, methylphenidate is contraindicated in patients being treated (currently or within the preceding 2 weeks) with non-selective, irreversible MAO-inhibitors (see section 4.3 Contraindications).
UCB PHARMA LIMITED, BATH ROAD, SLOUGH, BERKSHIRE SL1 3WE DET FORENEDE KONGERIGE 
UCB PHARMA LIMITED, BATH ROAD, SLOUGH, BERKSHIRE SL1 3WE UNITED KINGDOM
De hyppigst indberettede psykiatriske bivirkninger af interesse unormal adfærd, unormal tankegang, vrede, fjendtlighed, aggression, agitation, tics gråd, depression, somnolens, forværring af ADHD, psykomotorisk hyp vrede, nervøsitet, psykotisk lidelse, stemningssvingninger, sygelig tankegang tilstand suicidalitet. 
Most frequently reported psychiatric adverse events of interest from spontaneous reports were abnormal behaviour, abnormal thinking, anger, hostility, aggression, agitation, tic, irritability, anxiety, crying, depression, somnolence, aggravated ADHD, psychomotor hyperactivity, emotional disorder, anger, nervousness, psychotic disorder, mood swings, morbid thoughts, obsessive-compulsive disorder, personality change/disorder, restlessness, confusional state, hallucinations, lethargy, paranoia and suicidality.
DE - Tysklan 1 A Pharma GmbH rhaching 
DE - Germany 1 A Pharma GmbH Keltenring 1 + 3
data for mere end indikerede hverken en moderat eller en stærk forbindelse mellem brug af ethy n af de 18 angivne cancerforsøgscentre. 
The recently published retrospective case control review of prescription records for more than 35,000 patients did not indicate either a moderate or a strong association between methylphenidate use and cancer risk in children for any of 18 defined cancer sites.
Benefit/risk-forholdet Efter at have taget disse elementer i betragtni 
Benefit/risk
JANSSEN-CILAG LIMITED, SAUNDERTON, HIGH WYC BUCKINGHAMSHIRE, HP1 
JANSSEN-CILAG LIMITED, SAUNDERTON, HIGH WYCOMBE, BUCKINGHAMSHIRE, HP14 4HJ, UNITED KINGDOM
Hjælpestoffer: galactose-/saccharoseintolerans {Udfyldes om nødvendigt nationalt} 
Excipients: galactose/sucrose intolerance
Selv om visse misdannelser i hjertet i sig selv kan in for pludselig død, anbefales stimulerende stoffer ikke til børn eller unge med kendte strukturelle hjerteproblemer, som k stimulerende lægemiddel. 
Although some serious heart problems alone may carry an increased risk of sudden death, stimulant products are not recommended in children or adolescents with known cardiac structural abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious cardiac problems that may place them at increased vulnerability to the sympathomimetic effects of a stimulant medicine.
ES - Spanien Medice Arznemitel Putter GMBH Kuhloweg, 37 D 58638 
ES - Spain Medice Arznemitel Putter GMBH Kuhloweg, 37 D 58638
4.7 Virkning på evnen til at føre motorkøretøj eller betjene m Methylphenidat kan forårsage svimmelhed, døsighed og synsforstyrrelser, inklusiv akkommodationsbesvær, diplopi og sløret syn. 
Methylphenidate can cause dizziness, drowsiness and visual disturbances including difficulties with accommodation, diplopia and blurred vision.
Forværring af forudeksisterende psykotiske eller maniske symptomer mindre de gavnlige virkninger opvejer risici for patienten. 
In the case of emergent psychiatric symptoms or exacerbation of preexisting psychiatric disorders, methylphenidate should not be given unless the benefits outweigh the risks to the patient.
Efter drøftelserne i CHMP blev man enige om, at der stadig savnes data fra langtidsbrug om en delser. 
Following the discussions at the CHMP it was agreed that long-term use data is still needed on a potential effect of methylphenidate on cardiovascular and cerebrovascular events.
I'er) mod depression eller har taget rrelser ighedsforstyrrelse igere har lidt af svær og tilbagevendende (type I) bipolar e, smerter og ubehag i eller væsentlige problemer med hjertets struktur eller funktion, 
- have a diagnosis or history of severe and episodic (Type I) Bipolar (affective) Disorder - has heart problems such as a history of a heart attack, irregular heartbeat, pain and discomfort in the chest, heart failure, heart disease or significant problems with the structure or function of the heart that were present at birth.
IE - Irland Janssen-Cilag Ltd, Saunderton, High Buckinghamshire, England. 
IE - Ireland Janssen-Cilag Ltd, Saunderton, High Wycombe HP14 4HJ,
Novartis Pharma GmbH Straße 59 
AT - Austria Novartis Pharma GmbH Brunner Straße 59
Alkohol kan forværre CNS-bivirkningerne af psykofarmaka, herunder methyl derfor, at patienter undgår alkohol under behandlingen. 
Alcohol may exacerbate the adverse CNS effects of psychoactive drugs, including methylphenidate.
GmbH rg d Novartis Pharma D-90327 Nuernbe 
DE - Germany Novartis Pharma GmbH D-90327 Nuernberg
Europaar af den opfattelse, at visse potentielle sikkerhedsproblemer, heriblandt hjerte-kard methylphenidat skulle 
The EC considered that some safety concerns, including cardiovascular and cerebrovascular disorders, potentially associated with methylphenidate treatment should be evaluated.
markedsføringstilladelse 
Marketing Authorisation Holder
at må ikke g ikke methylphenidat, hvis du eller dit barn er overfølsom (allergisk) methylphenidat har forhøjet tryk i øjet (grøn stær) har en tumor i binyren tager lægemidler kaldet monoaminoxidasehæmmere (MAO MAOI'er inden for de seneste 14 dage har problemer med skjoldbruskkirtlen lider af anoreksi (nervøs spisevægring) eller anoreksilignende forsty lider af depression, stemningsforstyrrelser, mani eller har selvmordstanker har psykotiske symptomer eller skizofreni eller psykopatisk/borderline personl har en diagnose på eller tidl (maniodepressiv) affektiv sindslidelse har hjerteproblemer som tidligere hjerteanfald, uregelmæssig hjerterytm brystet, hjertesvigt, hjertesygdom som har været til stede ved fødslen 
- have glaucoma (increased pressure in the eye) - have phaeochromocytoma (a tumour of the adrenal gland) - are taking medicines known as monoamine oxidase inhibitors (MAOIs) for depression, or have taken MAOIs in the last 14 days - have thyroid problems - suffer from anorexia nervosa or anorexic disorders - suffer from depression, mood disorders, mania, or have suicidal thoughts - suffer from psychotic symptoms or schizophrenia or psychopathic/borderline personality disorder.
Angina einf arkt 
Rare: angina pectoris
medicinske og specialiserede psykologiske, 
Adequate diagnosis requires the use of medical and specialised psychological, educational, and social resources.
Behandlingen skal overvåges af en specialist i adfærdsf Lægemiddelbehandling afbrydes som regel under eller efter puberteten. 
Drug treatment is usually discontinued during or after puberty.
Methylfenidaat HCl 10 mg PCH 10 mg 
Methylfenidaat HCl 10 mg PCH 10 mg tablets
UCB Nordic A/S Arne Jacobsens A 2300 Københa Danmark 
UCB Nordic A/S Arne Jacobsens Allé 15 2300 Köbenhavn S Denmark
e skal overvåges for risikoen for afhængighed og misbrug af methylphenidat. 
Your child should be monitored for the risk of diversion, misuse and abuse of methylphenidate.
Novartis Healthcare A/S, c/o Vistor hf., Hörgatún 2, 212 Garðabær, Island 
Novartis Healthcare A/S, c/o Vistor hf., Hörgatún 2, 212 Garðabær, Iceland
potentiel virkning af methylphenidat på kardiovaskulære og cerebrovaskulære hæn der behov for flere data for at vurdere de psykiatriske behandlingsresultater samt in vækst og udvikling hos børn. 
In addition more data is needed to assess the psychiatric outcome as well as the effect on growth and development of the children.
<Spørg lægen eller på apoteket, hvis der er noget, <De><du> er 
<If you have any further questions on the use of this product, ask your <doctor> <or> <pharmacist>.>
Almindelig: ledsmerter 
Uncommon: constipation
Laboratorios RUBIO, SA Industria 29- Polígono in Comte de Sert 
ES - Spain Laboratorios RUBIO, SA Industria 29- Polígono industrial Comte de Sert
MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG; KUHLOWEG 37; ISERLOHN 58638; TYSKLAND 
MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG; KUHLOWEG 37; ISERLOHN 58638; GERMANY
Et af de vigtigste formål med de methylphenidat på blodtryk og hjertefrekvens. 
The analysis of the data provided by MAHs showed a highly variable effect of methylphenidate on blood pressure and heart rate.
NOVARTIS PHARMACEUTI UK LIMITED, FRIMLEY BU PARK, FRIMLEY, C SURREY GU16 7SR, 
NOVARTIS PHARMACEUTICALS UK LIMITED, FRIMLEY BUSINESS PARK, FRIMLEY, CAMBERLEY, SURREY GU16 7SR, UNITED KINGDOM
Det er således nødvendigt ordinerende læger og for offentligheden ved at skærpe ordlyden i produkternes prod Desuden er der igangværende kliniske undersøgelser af disse emner, og de e 
So, there is the need for this information to be clear to the prescribers and the public by strengthening the wording of the Product Information of the products.
ICD-10 og skal være baseret på en komplet anamnese og vurdering af patien En diagnose kan ikke udelukkende baseres på tilstedeværelse af et eller flere symptom 
Diagnosis cannot be made solely on the presence of one or more symptom.
Hvis midler baseres på ående vurdering af sværhedsgraden af barnets symptomer. 
Where remedial measures alone prove insufficient, the decision to prescribe a stimulant must be based on rigorous assessment of the severity of the child's symptoms.
Vaskulære mme* 
Vascular disorders*
08755-Castellbis SPANIEN 
Castellbisbal 08755
ALFRED E TIEFENBACHE & CO; VAN-DER-SMIS STRASSE 1; HAMBURG TYSKLAND 
ALFRED E TIEFENBACHER GMBH & CO; VAN-DER-SMISSEN-STRASSE 1; HAMBURG D-22767; GERMANY
d TAD Pharma Postfach 720 
DE - Germany TAD Pharma GmbH Postfach 720